Skip to main content
Clinical Trials/NCT07194499
NCT07194499CompletedNot Applicable

Knowledge and Attitude Among Healthcare Workers Towards Malaria Vaccine, Sudan 2025.

Research and Publication office1 site in 1 country222 target enrollmentStarted: January 16, 2025Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
222
Locations
1
Primary Endpoint
Knowledge regarding malaria vaccine

Study Overview

Brief Summary

This study assesses Sudanese healthcare workers' knowledge and attitudes toward the malaria vaccine in 2025, considering demographic and professional factors. It examines awareness of malaria prevalence, WHO recommendations, vaccine type, efficacy, and safety, along with confidence in recommending it and its acceptability. The findings will aid in designing interventions to improve vaccine uptake and reduce malaria burden.

Detailed Description

This study aims to assess the knowledge and attitudes of Sudanese healthcare workers (HCWs) toward the malaria vaccine in 2025. It examines how demographic factors and professional roles influence their understanding and perception. The knowledge assessment includes awareness of malaria prevalence, WHO vaccine recommendations, and vaccine type, efficacy, and safety. The attitude evaluation focuses on confidence in recommending the vaccine and perceptions of its feasibility and acceptance in Sudan. The findings will help design targeted interventions to enhance vaccine uptake and reduce the malaria burden.

Study Design

Study Type
Observational
Observational Model
Other
Time Perspective
Cross Sectional

Eligibility Criteria

Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Knowledge regarding malaria vaccine

Time Frame: Jan - Apr 2025

Included 11 questions about awareness, malaria and malaria vaccination

Attitude regarding malaria vaccine

Time Frame: Jan - Apr 2025

5 point likert-scale assessment

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
Research and Publication office
Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials